Explore more publications!
Martinique Science Reporter
Got News to Share?

Martinique Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Martinique Science Reporter.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 20, 2025

Brag House Holdings Merger Partner, House of Doge - The Official Corporate Arm of the Dogecoin Foundation - Makes History by Becoming the First Cryptocurrency Company To Buy A Professional Football Club
October 20, 2025

Brag House Holdings Merger Partner, House of Doge - The Official Corporate Arm of the Dogecoin Foundation - Makes History by Becoming the First Cryptocurrency Company To Buy A Professional Football Club

Indeterminate GlobeNewswire
American Rebel Holdings, Inc. (NASDAQ: AREB) Announces Breakout Success at 2025 NBWA Convention with Expanded National Distribution Footprint for American Rebel Light – America’s Patriotic and Fastest Growing Beer
October 20, 2025

American Rebel Holdings, Inc. (NASDAQ: AREB) Announces Breakout Success at 2025 NBWA Convention with Expanded National Distribution Footprint for American Rebel Light – America’s Patriotic and Fastest Growing Beer

Indeterminate GlobeNewswire
NewGen Announces Strategic Entry into Art Tokenization Market with $2 Million Private Collection Deal, Expandable to $200 Million
October 20, 2025

NewGen Announces Strategic Entry into Art Tokenization Market with $2 Million Private Collection Deal, Expandable to $200 Million

Indeterminate GlobeNewswire
XBP Global Partners with the New York City Department of Finance for Enhanced Parking Violation Payment Processing
October 20, 2025

XBP Global Partners with the New York City Department of Finance for Enhanced Parking Violation Payment Processing

Indeterminate GlobeNewswire
EXL announces appointment of Patrick Geraghty to Board of Directors
October 20, 2025

EXL announces appointment of Patrick Geraghty to Board of Directors

Indeterminate GlobeNewswire
Akebia Therapeutics Announces Five Presentations at ASN Kidney Week 2025
October 20, 2025

Akebia Therapeutics Announces Five Presentations at ASN Kidney Week 2025

Indeterminate GlobeNewswire
IMUNON Hosts R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer
October 20, 2025

IMUNON Hosts R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer

Indeterminate GlobeNewswire
Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025
October 20, 2025

Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025

Indeterminate GlobeNewswire
OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET
October 20, 2025

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET

Indeterminate GlobeNewswire
MBX Biosciences to Participate in November Investor Conferences
October 20, 2025

MBX Biosciences to Participate in November Investor Conferences

Indeterminate GlobeNewswire
Arnatar Therapeutics Announces Upcoming Presentations at AASLD The Liver Meeting® 2025 and ASN Kidney Week 2025
October 20, 2025

Arnatar Therapeutics Announces Upcoming Presentations at AASLD The Liver Meeting® 2025 and ASN Kidney Week 2025

Indeterminate GlobeNewswire
GSI Technology to Announce Fiscal Second Quarter 2026 Results on October 30, 2025
October 20, 2025

GSI Technology to Announce Fiscal Second Quarter 2026 Results on October 30, 2025

Indeterminate GlobeNewswire
BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025
October 20, 2025

BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025

Indeterminate GlobeNewswire
Certara Scientists are Among the Topmost Cited Biopharma Researchers
October 20, 2025

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Indeterminate GlobeNewswire
Judo Bio Presents Data Demonstrating Sustained, Kidney-Selective Gene Silencing Across Species
October 20, 2025

Judo Bio Presents Data Demonstrating Sustained, Kidney-Selective Gene Silencing Across Species

Indeterminate GlobeNewswire
IDI Announces Integration with TazWorks to Expand Access to IDI’s Best-in-Class Identity Intelligence in the Background Screening Industry
October 20, 2025

IDI Announces Integration with TazWorks to Expand Access to IDI’s Best-in-Class Identity Intelligence in the Background Screening Industry

Indeterminate GlobeNewswire
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
October 20, 2025

Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025

Indeterminate GlobeNewswire
Two Posters at ESMO Congress 2025 Highlight Immutep’s Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer
October 20, 2025

Two Posters at ESMO Congress 2025 Highlight Immutep’s Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire
Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion
October 20, 2025

Reverba Global Introduces ClinOps G.P.S.™ to Set a New Course for Clinical Trial Execution and Chart a Clearer Path from Protocol to Completion

Indeterminate GlobeNewswire
Oncotelic to Present at the LD Micro Main Event XIX
October 20, 2025

Oncotelic to Present at the LD Micro Main Event XIX

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions